Cancer Research UK
Also known as: Cancer Research UK | Cancer Research UK Cambridge Institute | Cancer Research UK Centre, Southampton University Hospitals and University of Southampton, Southampton SO16 6YD | Cancer Research UK (CRUK) | Cancer Research UK Edinburgh Centre | Cancer Research UK, Glasgow | Cancer Research UK Medical Oncology Unit, Southampton General Hospital, | Cancer Research UK, The Institute of Cancer Research, London, UK | Cancer Research UK & UCL Cancer Trials Centre | Liz-Anne Lewsley
Highest phase reached
Phase 3
First clinical trial
Feb 4, 2002Last known activity
Dec 1, 2025
Timeline
2000s
- Feb 4, 2002
Cancer Research UK— Founded
Drugs by trial phase (205 distinct, 194 trials)
Phase 3 (94 own, 0 via acquisition)
Phase 2 (70 own, 0 via acquisition)
Phase 1 (38 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenomyoepithelioma
- Anus Neoplasms
- Biliary Tract Neoplasms
- Brain Neoplasms
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carotid Body Tumor
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Choriocarcinoma
- Colorectal Neoplasms
- Dementia
- Disease Progression
- Endodermal Sinus Tumor
- Endometrial Neoplasms
- Enteropathy-Associated T-Cell Lymphoma
- Epstein-Barr Virus Infections
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Frailty
- Gallbladder Neoplasms
- Germinoma
- Glioblastoma
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hodgkin Disease
- Immunoblastic Lymphadenopathy
- Intestinal Neoplasms
- Kidney Neoplasms
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Mantle-Cell
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Lymphoproliferative Disorders
- Melanoma
- Mesothelioma
- Mucositis
- Multiple Myeloma
- Myelodysplastic Syndromes
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuroblastoma
- Neuroendocrine Tumors
- Neurotoxicity Syndromes
- Oropharyngeal Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Paraganglioma
- Parkinson Disease
- Pheochromocytoma
- Plasmacytoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Rectal Neoplasms
- Sarcoma
- Sarcoma, Kaposi
- Seminoma
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Teratoma
- Testicular Neoplasms
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Uveal Neoplasms
- Virus Diseases
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT07095517CollaboratorPhase 1Dec 1, 2025
- NCT06529718CollaboratorPhase 2Jan 30, 2025
- NCT06988475Lead sponsorPhase 2/Phase 3Nov 19, 2024
- NCT06630260CollaboratorPhase 1/Phase 2Nov 4, 2024
- NCT06632236CollaboratorPhase 1Oct 9, 2024
- NCT05615818CollaboratorPhase 3Jul 18, 2024
- NCT05615818CollaboratorPhase 3Jul 18, 2024
- NCT06380816Lead sponsorPhase 1/Phase 2Jul 9, 2024
- NCT06320067CollaboratorPhase 3Jun 11, 2024
- NCT05770544Lead sponsorPhase 2/Phase 3Dec 31, 2023
- NCT05770102Lead sponsorPhase 2/Phase 3Nov 30, 2023
- NCT06045910Lead sponsorPhase 1/Phase 2Nov 30, 2023
- NCT05991388CollaboratorPhase 2/Phase 3Oct 31, 2023
- NCT05770037Lead sponsorPhase 2/Phase 3Oct 31, 2023
- NCT05848765CollaboratorPhase 2Sep 4, 2023
Details
- Founded
- London, GB Feb 4, 2002
- Last known activity
- Dec 1, 2025